Tag Archives | Sexually Transmitted Disease

Frightening ‘Super Gonorrhea’ Strain Emerges

gty_gonorrhea_sc_110708_wgIt has been found in Japan, the country from which new strains have typically originated in the past. (Due to their love hotels?) It could go global in a decade, writes Reuters:

Scientists have found a “superbug” strain of gonorrhea in that is resistant to all antibiotics and say it could transform a once easily treatable infection into a global public health threat.

The new strain of the sexually transmitted disease — called H041 — cannot be killed by any currently recommended treatments for gonorrhea, leaving doctors with no other option than to try medicines so far untested against the disease.

Magnus Unemo of the Swedish Reference Laboratory for Pathogenic Neisseria, who discovered the strain with colleagues from Japan in samples from Kyoto, described it as both “alarming” and “predictable.”

In a telephone interview Unemo said the fact that the strain had been found first in Japan also followed an alarming pattern — “Japan has historically been the place for the first emergence and subsequent global spread of different types of resistance in gonorrhea,” he said.

Read the rest

Continue Reading

Daily Pill Helps Prevent HIV Infection

120px-HIV-budding-ColorWhile this pill would be an amazing achievement helping to reduce the spread of HIV, even the volunteers in the trial couldn’t remember to take it everyday. The best prevention of HIV is the knowledge of how it is transmitted and how ways to prevent it. From BBC News:

A daily pill to prevent HIV infection would be a significant development. A trial published in the New England Journal of Medicine suggests that an established treatment for HIV infection is also powerful in protecting gay men from catching the virus.

This is not, however, the answer to the nearly 30 year epidemic of HIV and AIDS. Since it is just one trial, many more studies will need to follow. But according to the Terrence Higgins Trust (THT) it is “potentially very significant and could change the HIV landscape in the future”.

Some brief facts about the trial: it involved about 2,500 men at high risk of HIV infection in Peru, Ecuador, Brazil South Africa, Thailand and the United States (San Francisco and Boston).

Read the rest

Continue Reading